

Austal remains a strong buy despite recent share price weakness and sector underperformance amid global tensions. Near-term upside is limited by supply chain constraints and inflationary pressures, but longer-term revenue stability is supported by persistent defense demand. Current risks center on input cost inflation and capital expenditure impacts, though these are expected to materialize with a 1.5–3 year lag.

Austal is upgraded to strong buy with a $5.20 price target, implying 47% upside amid rising peer valuations. H1 2026 revenues surged 34.4% to A$1.1B, but EBITDA margins contracted due to program transitions and loss provisions. 2026 guidance was revised down by A$17.1M after an accounting error, leading to EBIT guidance of A$110M and management changes.

Austal Limited (AUTLF) Q2 2026 Earnings Call Transcript

Austal Limited (OTCPK:AUTLF) Shareholder/Analyst Call October 28, 2025 2:00 AM EDT Company Participants Richard Spencer Patrick Gregg - CEO, MD & Executive Director Conversation Richard Spencer Good afternoon, ladies and gentlemen. On behalf of the Board, I'd like to welcome you to the 2025 Annual General Meeting of Austal Limited.

Austal's stock price has surged 30% since January, driven by strong H1 FY25 earnings and a robust A$14.2 billion backlog. Despite risks like currency exposure and high capital intensity, opportunities in defense contracts and increased support demand offer significant growth potential. H1 FY25 results show 15% revenue growth to A$826 million, with EBITDA up 21% and EBIT up 32.7%, driven by strong performance in Australasia.

Austal's stock has surged 40% since my buy rating, driven by significant contracts and positive guidance for FY25, despite no new earnings reports. Major contracts include a $450M deal with General Dynamics and a $152M direct award from the US Navy, bolstering Austal's role in submarine support. The company faces risks from cost overruns and currency fluctuations, but has a strong backlog and growth potential in marine defense investments.
No recent filings indexed.